[go: up one dir, main page]

RU2002100058A - 1-Methylcarbapenem Crystal Derivatives - Google Patents

1-Methylcarbapenem Crystal Derivatives

Info

Publication number
RU2002100058A
RU2002100058A RU2002100058/04A RU2002100058A RU2002100058A RU 2002100058 A RU2002100058 A RU 2002100058A RU 2002100058/04 A RU2002100058/04 A RU 2002100058/04A RU 2002100058 A RU2002100058 A RU 2002100058A RU 2002100058 A RU2002100058 A RU 2002100058A
Authority
RU
Russia
Prior art keywords
methylcarbapenem
derivative
crystalline form
formula
prevention
Prior art date
Application number
RU2002100058/04A
Other languages
Russian (ru)
Other versions
RU2214411C2 (en
Inventor
Исао Кавамото
Ясуо СИМОДЗИ
Хироси ФУКУХАРА
Original Assignee
Санкио Компани, Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани, Лимитед filed Critical Санкио Компани, Лимитед
Publication of RU2002100058A publication Critical patent/RU2002100058A/en
Application granted granted Critical
Publication of RU2214411C2 publication Critical patent/RU2214411C2/en

Links

Claims (8)

1. Производное 1-метилкарбапенема формулы (I) или его фармацевтически приемлемая соль в кристаллической форме1. A derivative of 1-methylcarbapenem of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form
Figure 00000001
Figure 00000001
 2. Производное 1-метилкарбапенема формулы (I-1) в кристаллической форме2. A derivative of 1-methylcarbapenem of the formula (I-1) in crystalline form
Figure 00000002
Figure 00000002
 3. Производное 1-метилкарбапенема формулы (I-2) в кристаллической форме3. The derivative of 1-methylcarbapenem of the formula (I-2) in crystalline form
Figure 00000003
Figure 00000003
 4. Производное 1-метилкарбапенема формулы (I) в кристаллической форме
Figure 00000004
4. The derivative of 1-methylcarbapenem of formula (I) in crystalline form
Figure 00000004
 5. Производное 1-метилкарбапенема формулы (I-3) в кристаллической форме5. The derivative of 1-methylcarbapenem of the formula (I-3) in crystalline form
Figure 00000005
Figure 00000005
 6. Фармацевтическая композиция для профилактики или лечения бактериальных инфекционных заболеваний, содержащая кристаллическую форму производного 1-метилкарбапенема или его фармацевтически приемлемой соли по любому из пп.1-5 в качестве активного ингредиента.6. A pharmaceutical composition for the prevention or treatment of bacterial infectious diseases, containing a crystalline form of a derivative of 1-methylcarbapenem or its pharmaceutically acceptable salt according to any one of claims 1 to 5 as an active ingredient. 7. Применение кристаллической формы производного 1-метилкарбапенема или его фармацевтически приемлемой соли по любому из пп.1-5 в качестве активного ингредиента лекарственного средства для профилактики или лечения бактериальных инфекционных заболеваний.7. The use of a crystalline form of a derivative of 1-methylcarbapenem or its pharmaceutically acceptable salt according to any one of claims 1 to 5 as an active ingredient of a medicament for the prevention or treatment of bacterial infectious diseases. 8. Способ профилактики или лечения бактериальных инфекционных заболеваний, который включает введение теплокровному животному, нуждающемуся в такой профилактике или лечении, фармакологически эффективного количества кристаллической формы производного 1-метилкарбапенема или его фармацевтически приемлемой соли по любому из пп.1-5.8. A method for the prevention or treatment of bacterial infectious diseases, which comprises administering to a warm-blooded animal in need of such prevention or treatment, a pharmacologically effective amount of a crystalline form of the 1-methylcarbapenem derivative or its pharmaceutically acceptable salt according to any one of claims 1 to 5.
RU2002100058/04A 1999-07-06 2000-07-06 Crystalline derivatives of 1-methylcarbapenem RU2214411C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19136899 1999-07-06
JP11/191,368 1999-07-06
JP11/191368 1999-07-06

Publications (2)

Publication Number Publication Date
RU2002100058A true RU2002100058A (en) 2003-06-27
RU2214411C2 RU2214411C2 (en) 2003-10-20

Family

ID=16273433

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2002100058/04A RU2214411C2 (en) 1999-07-06 2000-07-06 Crystalline derivatives of 1-methylcarbapenem
RU2003118411/04A RU2003118411A (en) 1999-07-06 2003-06-18 1-Methylcarbapenem Crystal Derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2003118411/04A RU2003118411A (en) 1999-07-06 2003-06-18 1-Methylcarbapenem Crystal Derivatives

Country Status (21)

Country Link
US (3) US20020128254A1 (en)
EP (1) EP1193269A4 (en)
JP (1) JP3476420B2 (en)
KR (1) KR100750552B1 (en)
CN (2) CN100360530C (en)
AU (1) AU758190B2 (en)
BR (1) BR0012253A (en)
CA (1) CA2378483C (en)
CZ (1) CZ20014731A3 (en)
HK (1) HK1044768A1 (en)
HU (1) HUP0202255A3 (en)
IL (2) IL147214A0 (en)
MX (1) MXPA02000061A (en)
NO (1) NO327786B1 (en)
NZ (1) NZ516310A (en)
PL (1) PL352296A1 (en)
RU (2) RU2214411C2 (en)
TR (2) TR200403436T2 (en)
TW (1) TWI250160B (en)
WO (1) WO2001002401A1 (en)
ZA (1) ZA200110413B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020060067A (en) 1999-04-06 2002-07-16 가와무라 요시부미 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
US7041660B2 (en) * 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
WO2001023393A1 (en) * 1999-09-30 2001-04-05 Otsuka Kagaku Kabushiki Kaisha 3-cephem derivative crystal and method for preparing the same
KR100858945B1 (en) 2000-06-21 2008-09-17 큐비스트 파마슈티컬즈 인코포레이티드 Compositions and methods for improving oral absorption of antimicrobial agents
KR100451672B1 (en) * 2001-06-05 2004-10-08 한미약품 주식회사 Crystalline acid salts of cefdinir, process for their preparation and process for the preparation of cefdinir using same
US20040198973A1 (en) * 2001-08-13 2004-10-07 Tsujii Masahiko Process for preparation of carbapenem antibiotics
RS52410B (en) 2001-09-26 2013-02-28 Merck Sharp & Dohme Corp. PROCESS OF MAKING CARBAPENEM UNITS
HRP20040264B1 (en) * 2001-09-26 2012-07-31 Merck@Sharp@@@Dohme@Corp Process for making carbapenem compounds
ITMI20012364A1 (en) * 2001-11-09 2003-05-09 Antibioticos Spa SUMMARY PROCESS OF CEFIXIMA VIA ALCHIL-O ARILSOLFONATI
JP2005097278A (en) * 2003-08-25 2005-04-14 Sankyo Co Ltd Crystal of 1-methylcarbapenem compound
BRPI0413842A (en) * 2003-08-25 2006-10-24 Sankyo Co compound of 1-methyl carbapenem or a pharmacologically acceptable salt thereof, ethanolate and tetrahydrate of 1-methyl carbapenem compound, process for preparing the crystalline form, process for preparing an ethanolate trihydrate of compound 1-methyl carbapenem, 1-methyl carbapenem compound ethanolate trihydrate, pharmaceutical composition for preventing or treating bacterial infections, and use of the crystalline form
ES2370829T3 (en) * 2004-06-02 2011-12-23 Sandoz Ag INTERMEDIATE PRODUCT OF MEROPENEM IN CRYSTAL FORM.
BRPI0608931A2 (en) * 2005-03-22 2010-11-09 Daiichi Sankyo Co Ltd compound or a salt thereof, and process for the preparation thereof
NZ580951A (en) 2005-04-29 2011-06-30 Cubist Pharm Inc Therapeutic compositions
US20080227768A1 (en) * 2005-05-13 2008-09-18 Makoto Michida Crystal of 1-Methylcarbapenem Compound
CN101328179B (en) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 Mercaptopyrrolidopenem derivatives containing oxo nitrogen heterocycle
CN101412717B (en) * 2007-10-19 2011-01-12 山东轩竹医药科技有限公司 Carbapenem derivative containing guanidyl alkanoylamino heterocycle
WO2009091031A1 (en) * 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. Method for producing adenine compound
US20130079322A1 (en) * 2010-05-21 2013-03-28 Xuanzhu Pharama Co., Ltd. Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof
US8822445B2 (en) * 2010-06-03 2014-09-02 Xuanzhu Pharma Co., Ltd. Crystalline form of carbapenem derivative or its hydrates and preparation methods and uses thereof
WO2014111113A1 (en) * 2013-01-15 2014-07-24 Merck Patent Gmbh Acylguanidines for treating osteoarthritis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260543A (en) 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4748238A (en) 1984-03-14 1988-05-31 Merck & Co., Inc. Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid
US4713451A (en) 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
IE60588B1 (en) 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
US4866171A (en) 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
TW209220B (en) * 1991-11-27 1993-07-11 Manyu Seiyaku Kk
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
ATE178066T1 (en) 1992-11-17 1999-04-15 Sankyo Co CRYSTALLINE CARBAPENEM DERIVATIVE
JPH06336483A (en) * 1993-05-26 1994-12-06 Banyu Pharmaceut Co Ltd Aminoalkylpyrrolidinyl thiocarbapenem derivatives
JPH07291973A (en) * 1994-04-27 1995-11-07 Banyu Pharmaceut Co Ltd Novel 2-pyrrolidinylthiocarbapenem derivative
JPH09110869A (en) * 1995-10-23 1997-04-28 Lederle Japan Ltd Carbapenem compounds
PT882728E (en) 1995-12-21 2002-11-29 Sankyo Co 1-METILCARBAPENEM DERIVATIVES
JP2955276B2 (en) * 1997-06-19 1999-10-04 三共株式会社 Antibacterial agent containing 1-methylcarbapenem derivative

Similar Documents

Publication Publication Date Title
RU2002100058A (en) 1-Methylcarbapenem Crystal Derivatives
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
EP1772142A3 (en) Organic compounds
WO2005056524A3 (en) Therapeutic agents useful for treating pain
ATE286501T1 (en) PYRIMIDINE DERIVATIVES
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
EP1797878A3 (en) Benzothiazole derivatives
EP1659111A3 (en) Piperidine derivatives useful as ccr5 antagonists
EE200100558A (en) A triaryl acid derivative, a pharmaceutical composition comprising it, and a compound for therapeutic use
EA201000643A1 (en) SUBSTITUTED PRODUCTION OF ETHYLENEDIAMIN FOR THE TREATMENT OF MYCOBACTERIAL DISEASES AND PHARMACEUTICAL COMPOSITION ON ITS BASIS
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
JP2000159790A5 (en)
ATE386725T1 (en) HETEROCYCLYL COMPOUNDS
SE9901573D0 (en) New compounds
NO941276D0 (en) Lipophilic, oligosaccharide antibiotic salt preparations
SE0302573D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
RU2003118411A (en) 1-Methylcarbapenem Crystal Derivatives
EP0992509A3 (en) Novel macrolide derivatives
DK1228758T3 (en) Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease
JP2002522501A5 (en)
EP1857442A3 (en) Novel antimycobacterial compounds
SE0302570D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria